USA flag logo/image

An Official Website of the United States Government

STTR Phase II: Monolithic Multiwavelength Blue-to-IR LED for Biomedical…

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
84933
Program Year/Program:
2009 / STTR
Agency Tracking Number:
0712295
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Valencell Inc.
2800-154 sumner blvd RALEIGH, NC 27616-2970
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2009
Title: STTR Phase II: Monolithic Multiwavelength Blue-to-IR LED for Biomedical Diagnostics
Agency: NSF
Contract: 0848943
Award Amount: $500,000.00
 

Abstract:

This Small Business Technology Transfer (STTR) Phase II project, in collaboration with North Carolina State University, will develop and validate an innovative, mobile, multiwavelength pulse oximetry module for noninvasive health monitoring of various blood metabolites simultaneously in real time. At the heart of this pulse oximetry module will be a novel multiwavelength emitter having independent control of up to nine spectrally narrow wavelengths, ranging from blue to mid-IR, emitting from a single 1 mm2 LED die. In contrast with traditional dual-wavelength pulse oximetry, which measures oxygen saturation in the blood, the proposed multiwavelength LED will enable real-time analysis several additional metabolites critical to health monitoring via the same noninvasive paradigm. Furthermore, the individually controlled self-aligned wavelengths enable superior motion artifact cancellation, which is essential for eHealth and mobile fitness applications. The key objectives of this feasibility study are to: Demonstrate luminescent films with peak emissions from 400-1100 nm Integrate these films into a compact multiwavelength pulse oximetry module Optimize novel pulsing algorithms for multiwavelength pulse oximetry Validate the mobile multiwavelength pulse oximetry module in a lab setting The medical impact of dual-wavelength pulse oximetry, in both saving lives and reducing healthcare costs, has encouraged the development of broader platforms using additional optical wavelengths. Incorporating 3 or more independently controlled wavelengths has been shown to enable the real-time monitoring of multiple health factors while further reducing readout errors ? thus saving more lives. Beyond blood oxygen monitoring, a real-time noninvasive assessment of renal and hepatic health can be realized by integrating several wavelengths in the same clinically accepted pulse oximetry paradigm. Though multispectral pulse oximetry systems incorporating several optical sources have been successfully demonstrated by physicians and industry leaders, incorporating multiple LEDs (made from dissimilar semiconductors) has led to costly reliability errors and even product recalls. If successful the proposed mobile, multiwavelength single-die approach surmounts these limitations by providing independent control of several wavelengths from a single, self-aligned, compact LED. Integrating these advanced, cost-effective optical sources into traditional pulse oximetry opens up new markets in noninvasive metabolic monitoring for clinical research, paramedics, physical therapists, drug discovery, consumer eHealth markets, and home healthcare. As a spectroscopic source, other applications include air-quality/pollution monitoring and agricultural/industrial controls.

Principal Investigator:

Steven F. LeBoeuf
PhD
9197936977
leboeuf@valencell.com

Business Contact:

Steven F. LeBoeuf
PhD
9197936977
leboeuf@valencell.com
Small Business Information at Submission:

Valencell Inc.
920 Main Campus Drive Suite 101 raleigh, NC 27606

EIN/Tax ID: 205493056
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
North Carolina State University
920 Main Campus Drive
Suite 101
Raleigh, NC 27606-1046
Contact: John Chaffee
Contact Phone: (919) 515-2444
RI Type: Nonprofit college or university